tiprankstipranks
Trending News
More News >
Bruker Corp (BRKR)
NASDAQ:BRKR
US Market
Advertisement

Bruker (BRKR) Earnings Dates, Call Summary & Reports

Compare
473 Followers

Earnings Data

Report Date
Feb 17, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.65
Last Year’s EPS
0.76
Same Quarter Last Year
Moderate Buy
Based on 8 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 03, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there were positive developments such as improved order performance in Q3, successful cost-saving initiatives, and growth in certain segments like diagnostics and spatial biology, these were counterbalanced by revenue declines and operational challenges. The company faces ongoing difficulties in the U.S. academic and government markets, and some revenue is being deferred to the next fiscal year.
Company Guidance
During the Bruker Corporation Third Quarter 2025 Earnings Conference Call, the company provided updated guidance reflecting a challenging year, with organic revenue expected to decline by 4% to 5% for the full year 2025. Despite this, the quarter saw a meaningful sequential improvement with revenues reaching $860.5 million, a slight decrease of 0.5% year-over-year. The company's non-GAAP operating margin was 12.3%, down 260 basis points from the previous year, but up from 9.0% in Q2 2025. Non-GAAP EPS for Q3 2025 was $0.45, a sequential rise from Q2's $0.32, although down from $0.60 the previous year. Bruker's Scientific Instruments segment achieved a book-to-bill ratio greater than 1.0 for the first time in several quarters, driven by mid-single-digit organic bookings growth. Notably, there was a high teens percentage increase in ACA/GOV orders outside the U.S. The company expects significant margin expansion and double-digit EPS growth in 2026, buoyed by anticipated cost savings of up to $120 million, despite a challenging macroeconomic environment.
Improved Q3 Order Performance
Q3 2025 saw mid-single-digit percentage organic bookings growth, with significant improvements in the academic government market segment and biopharma orders. The book-to-bill ratio surpassed 1.0 for the first time in several quarters.
Successful Cost Savings Initiatives
Bruker's cost savings initiatives are on track towards the high end of the $100 million to $120 million target for 2026, expected to deliver significant margin expansion and double-digit EPS growth.
Strength in Diagnostics and Spatial Biology
The diagnostics segment, particularly the ELITech molecular diagnostics franchise, showed strong growth. Spatial biology solutions also gained traction with biopharma and academic customers.
Encouraging Signs from China
Organic scientific instruments orders in China increased by a double-digit percentage year-over-year in Q3 2025, with early signs of stimulus funding being dispersed.

Bruker (BRKR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BRKR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 17, 2026
2025 (Q4)
0.65 / -
0.76
Nov 03, 2025
2025 (Q3)
0.35 / 0.45
0.6-25.00% (-0.15)
Aug 04, 2025
2025 (Q2)
0.41 / 0.32
0.52-38.46% (-0.20)
May 07, 2025
2025 (Q1)
0.44 / 0.47
0.53-11.32% (-0.06)
Feb 13, 2025
2024 (Q4)
0.74 / 0.76
0.78.57% (+0.06)
Nov 05, 2024
2024 (Q3)
0.60 / 0.60
0.74-18.92% (-0.14)
Aug 06, 2024
2024 (Q2)
0.51 / 0.52
0.54.00% (+0.02)
May 02, 2024
2024 (Q1)
0.47 / 0.53
0.64-17.19% (-0.11)
Feb 13, 2024
2023 (Q4)
0.68 / 0.70
0.74-5.41% (-0.04)
Nov 02, 2023
2023 (Q3)
0.63 / 0.74
0.6612.12% (+0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BRKR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 03, 2025
$38.94$38.71-0.59%
Aug 04, 2025
$37.93$34.66-8.62%
May 07, 2025
$39.34$40.64+3.30%
Feb 13, 2025
$51.45$50.95-0.97%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bruker Corp (BRKR) report earnings?
Bruker Corp (BRKR) is schdueled to report earning on Feb 17, 2026, After Close (Confirmed).
    What is Bruker Corp (BRKR) earnings time?
    Bruker Corp (BRKR) earnings time is at Feb 17, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BRKR EPS forecast?
          BRKR EPS forecast for the fiscal quarter 2025 (Q4) is 0.65.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis